Literature DB >> 28133001

A Review of the Pathogenesis of Toxic Epidermal Necrolysis.

Yuri Kinoshita1, Hidehisa Saeki.   

Abstract

Toxic epidermal necrolysis (TEN) is a rare skin condition, most often drug-induced, known for its skin detachment and high mortality. In general, acute TEN is considered a T-cell mediated, type IV hypersensitivity disorder. It mostly results from a cumulative effect of risks from the drug structure, drug metabolism, HLA alleles and T cell clonotypes. However, the precise mechanism of TEN is still unknown. Apoptosis or necroptosis causes keratinocytes to lose their shape and adhesion, and necrosis predominates within a few days. Total epidermal necrosis separates the epidermis from the dermis. TEN is regarded as an immune reaction with predominantly CD8+ T lymphocytes, monocytes/macrophages, and natural killer cells. Impaired regulatory T-cells, T-helper 17 cells, cytotoxic granules such as perforin-granzyme and granulysin, tumor necrosis factor α, annexin, microRNA-18a-5p, and drug metabolites are all thought to be involved. From what is known, it can be assumed their mechanism is complex, and there is still much to be investigated. New findings will contribute to the identification of effective active methods of intervention.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28133001     DOI: 10.1272/jnms.83.216

Source DB:  PubMed          Journal:  J Nippon Med Sch        ISSN: 1345-4676            Impact factor:   0.920


  6 in total

Review 1.  Toxic Epidermal Necrolysis and Steven-Johnson Syndrome: A Comprehensive Review.

Authors:  Olivia A Charlton; Victoria Harris; Kevin Phan; Erin Mewton; Chris Jackson; Alan Cooper
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-01-09       Impact factor: 4.730

2.  Allopurinol-induced toxic epidermal necrolysis featuring almost 60% skin detachment.

Authors:  Feifei Wang; Zhuo Ma; Xinan Wu; Lihong Liu
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

3.  Impact of Antibiotics Associated with the Development of Toxic Epidermal Necrolysis on Early and Late-Onset Infectious Complications.

Authors:  Bretislav Lipovy; Jakub Holoubek; Marketa Hanslianova; Michaela Cvanova; Leo Klein; Ivana Grossova; Robert Zajicek; Peter Bukovcan; Jan Koller; Matus Baran; Peter Lengyel; Lukas Eimer; Marie Jandova; Milan Kostal; Pavel Brychta; Petra Borilova Linhartova
Journal:  Microorganisms       Date:  2021-01-19

4.  Case Report: Wound Closure Acceleration in a Patient With Toxic Epidermal Necrolysis Using a Lyophilised Amniotic Membrane.

Authors:  Bretislav Lipový; Martin Hladík; Petr Štourač; Serhiy Forostyak
Journal:  Front Bioeng Biotechnol       Date:  2021-04-16

5.  Recurrent Steven-Johnson/Toxic Epidermal Necrolysis Overlap Syndrome.

Authors:  Juan F Toledo-Martinez; Ethel V Galdamez-Carcamo; Francisco J Somoza-Cano; Diego A Padilla-Mantilla; Karina L Alvarenga-Alvarado
Journal:  Cureus       Date:  2022-01-18

Review 6.  A contemporary snippet on clinical presentation and management of toxic epidermal necrolysis.

Authors:  Piyu Parth Naik
Journal:  Scars Burn Heal       Date:  2022-09-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.